Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Extended Peginterferon Plus Ribavirin Treatment for 72 Weeks Versus Standard Peginterferon Plus Ribavirin Treatment for 48 Weeks in Chronic Hepatitis C Genotype 1 Infected Slow-responder Adult Patients: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439804/0/Interventions_for_atypical_haemolytic_uraemic_syndrome_New. Accessed 28 March 2024.
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439804/0/Interventions_for_atypical_haemolytic_uraemic_syndrome_New. Accessed March 28, 2024.
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439804/0/Interventions_for_atypical_haemolytic_uraemic_syndrome_New
Extended Peginterferon Plus Ribavirin Treatment for 72 Weeks Versus Standard Peginterferon Plus Ribavirin Treatment for 48 Weeks in Chronic Hepatitis C Genotype 1 Infected Slow-responder Adult Patients: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439804/0/Interventions_for_atypical_haemolytic_uraemic_syndrome_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients: Cochrane systematic review
ID - 439804
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439804/0/Interventions_for_atypical_haemolytic_uraemic_syndrome_New
DB - Evidence Central
DP - Unbound Medicine
ER -